Misuse of antibiotics in humans and animals often leads to the development ofmultidrug resistance (MDR)bacteria. Resistance can occur within a few years of novel antibiotics being introduced. Lytic bacteriophage (phage) are a kind of virus that undergo a cyclical lifestyle wherein they infect and replicate through the use of a bacterial host cell and cause cell lysis. Phage recognizes specific receptors on their host cell to attach to,insert their DNA and take over their host's molecular machinery. These receptors only exist on the surface of specific bacterial host cells and are often not present on other non-specific bacteria and not especially on the surfaces of eukaryotic cells. The mechanisms by which phage can destroy bacteria are different from antibiotics; phage can lyse MDR resistant bacteria without being affected by hydrolytic enzymes or ribosomal variations that's mean unlike drug resistance mechanism which bacteria can destroy the drug before can inter the bacteria cell, the phage not effected with such enzyme.
Bacteriophages (phages) are viruses that insert their genomes into bacterial cells, rapidly taking control of the host's molecular machinery and produce progeny that are released by lysis of the bacterium. Phage therapy involves using phages as a treatment or prophylaxis application against infectious diseases caused by bacteria. The worldwide prevalence, persistence and incurabilityof pathogenic multidrug resistant bacteria is a serious public health concern that will bring about the post-antibiotic era. This result is primarily from the extensive use of antibiotics that puts selective pressure on bacteria to develop mechanisms of resistance 1 . Phage were first discovered separately by Fredrick Twort and Félix d'Herelle in the early 20 th century and later used heavily among Eastern Europe countries and the form Soviet Unionfor treating and preventing bacterial infectious diseases [2] [3] [4] .In more recent years an interest in phage therapy has been resurrected as a potential option to deal with MDR bacteria infections.
MRSA
Staphylococci are gram-positive bacteria that cause various infectious diseasesin humans and animals.Staphylococci are classified using different methods, one of the main categories on the basis of coagulase.Coagulase is a major factor that causes blood clotting in the proximity of the bacteria and bacteria lacking in these factors often make poor pathogens.Accordingly, the only specie of Coagulase-positive Staphylococci in this category is S. aureus.S. aureus initially was susceptible to Penicillin, but with time and indiscriminate use of antibiotics, resistant strains emerged along with ones that became resistant to more recent generations of β-lactam antibiotics. Methicillin was among the later generation drugs and became commonly used after the emergence ofPenicillin-resistant S. aureus 5, 6 .Two subsets of S.aureus strains are further distinguished based on resistance and susceptibility to Methicillin; MRSA (Methicillin Resistance Staphylococcus aureus), and MSSA (Methicillin Sensitive Staphylococcus aureus) (Fig. 1) .
Diseases caused by S. aureus include endocarditis, wound infection, carbuncle, toxic shock syndrome, osteomyelitis, etc.These bacteria produce a toxin that damage cells as well as being able to directly attack the cell to cause apoptosis using a Fibronectin Binding Protein 7 .Drug resistance in MRSA isthe result of a mecA gene that produces Penicillin-Binding Protein (PBP) witha lower affinity 8 . The PBP is a peptidogly cansynthesis protein and involved in the synthesis of peptidoglycan, which is the major component of bacterial cell walls.
Phage
Nearly 10 8 phage particles per ml are present in the oceans and an estimated 10 30 phage particles exist in the world.Phages can be divided based on features such as host range, absence or presence of an lipid envelope, physical characteristics (size and morphology of capsid and tails, if present), resistance to organic solvents, genome composition (single or double-stranded DNA or RNA) and if they have antigenic properties 9, 10 . Based on classification by the International Committee of Taxonomy of Viruses (ICTV) a vast majority of phages are in a one category called Caudovirales 9 , have one of three tail morphologies and ads DNA genome packaged a head-full into their capsid 11 .Phages are further divided into three types based on their life cycle: lysogenic, lytic and chronic 12 .The genome of a temperate phage, once inserted into the bacterial cytoplasm, integratesinto the host chromosome and can undergo a dormant state, even be replicated along with the host chromosome during binary fission and at a later time excise from the chromosome to form phage particles and utilize the lytic cycle 13 . Obligatorily lytic phages however inject their genome into the cytoplasm of the bacteria, hijack the cell and immediately convert it into producing progeny and shorty (or eventually a few hours later which is the case with T4-like phages due to lysis inhibition) releases them by destroying the bacteria through lysis. Chronic phage can replicate and release their progeny from the host without compromising the viability of their host.Phages can survive outside the host cell but utilization of the host is requiredfor replication 14 . Phage specificity can be used to further characterize bacterial strains through a method called phage typing 15, 16 .
There are several problems to identifying phagesone of which is that phages cannot be cultured outside of ahost 17 .Phage particleswill be comprised of a tail, a filamentous tube or polymorphous structure 11 .The composition of a Caudioviridae includes acapsid, disk plates that make a tail sheath, a base plate and aspike for Siphoviridae or multiple tail fibers for Podo-and Myoviridae. In addition to phage therapy, phage can be used for industrial purposes, including phage display, detection of pathogenic bacteria via luminescence 18 , provide bactericidal endolysin proteins that clear if not mitigate the prevalence of pathogens from food products 20 , enhanced food safety applications in agricultural and aqua culture settings, as a prophylactic and in hospitals to control biofilm-forming pathogens and common bacterial infections associated with hospital visits 19 .
Advantages of phage therapy
(A) Effective against MDR bacteria because they use significantly different mechanisms in comparison to antibiotics; (B) Phages are capable of evolving/mutating therefore, they can respond to phage-resistant bacteria; (C) Shifting of target organisms does not occur because it has high specificity and secondary infections are avoided 21 ; (D) Phages ortheir protein products, such holin and lysozyme,do not negatively affect eukaryotic cells 22, 23 ;(E) Phages can replicated at the site of a bacterial infection; (F)Phage-resistant bacteria are likely susceptible to other phages 24 .
Classification of phage and infection mechanism:
Phages are classified into 13 families according to nucleic acid type, morphology and the presence or absence of an envelope or lipid layer 22 . Most phages have a tail and are further classified into three families according to the morphological features of a tail: Myoviridae (a contractile tail most commonly found in T-even phages), Siphoviridae (long, flexible, non-contractile tail seen in T5) and Podoviridae (extremely short tail; e.g., T7) 25, 26 . Phage infections function much like other viruses wherein the ûrst step is to make contact with a receptor, usually a protein or sugar component on the bacterial surface. Phages are able to absorb to speciûc bacterial species and even to specific strains within a species; or genera within the same gram type which are called polyvalent phages 27 . The second step (for lytic phages specifically) is the injection of DNA into the bacterial cytoplasm, use the host RNA polymerase to express early mode genes from the phage genome, take over of the host by either degrading the host genome or ejecting it from the cell,replicate the phage genome, and synthesized multiple middle and late genes that encode proteins such as the capsid and tail, followed by the genomic DNA being packaged into the capsid, resulting in completed phage. In the last step, phages produce the endolysin that destroy the peptidoglycan of the cell wall allowing phage progeny to be released 28 . 
Phage and genetic engineering
Most gram-negative bacteria have extracellular lipopolysaccharide components that are often shared amongst different strains. Through the use of genetic engineering, we could modify the properties of a phage's tail fibers that could allow it to bind to one or more ofthe shared components found in most lipopolysaccharide of gram-negative bacteria of interest resulting in a wider host range. In a study conducted by Lorena Rodríguez-Rubio three different proteins uses between lysostaphin and HydH5 resulted in increased performances of the 2 proteins compared to the wild type and caused lysis of the bacteria in plate and reduce the opaqueness of bacteria in liquid media 29 .
Phage therapy vs. Antibiotic therapy against MRSA
The use of phage as an antimicrobial agent with similar efficacy to an antibiotic is one of the most exciting aspects in treating infections. A number of studies have shown the use of phage has no direct, negative effects on eukaryotic cells and the efficiency of phage can in some cases be greater than antibiotics. In addition, the problematic, disease-causing bacteria can be destroyed with no or minimal effect on neighboring and essential microbiotia. Smith et al. showed that a single intramuscular dose of one anti-K1 coliphage was more effective for treating mice challenged with E. coli intramuscularly than multiple intramuscular doses of Tetracycline, Chloramphenicol or Trimethoprim plus Sulfafurazole 30 . ChibaniChennouû et al. showed that all of the administered phage passed through the gastro in testinal tract in adult mice and destroyed a diarrheal E.coli strain 31 .Matsuzak et al. used four types of phage to treat 72 strainsof MRSA (Methicillin Resistance Staphylococcus aureus) and showed that injections of 8*10 8 bacteria intra-peritoneal,caused bacteremia and eventual death in mice but when administration simultaneously with puriûed phage ØMR11 (MOI ≥ 0.1) they suppressed S. aureus-induced lethality. High-doses of phage ØMR11 used on uninfected mice showed no adverse effects 32 44 .Phages specificity is due to their tail fibers' ability to bind to specific antigens on their host that aren't present on other non-target bacteria. In other words the use of phage to attack problematic bacteria is beneficial and not likely to have any negative effects on normal microbiota; an effect often not seen in conventional broad-spectrum antibiotics. Another advantage of phage is that they can replicate at the site of infection and easily overcome and out number the bacteria after a number of infection cycles. The likelihood of a naturally occurring phage being able to infect a eukaryotic cell is highly unlikely and probably even impossible without the extensive use of genetic engineering in a lab setting. The receptors on the outer membrane of eukaryotes are significantly foreign in comparison to those of bacteria, the phage wouldn't be able to penetrate the significantly thicker cell membrane, the inserted genome likely wouldn't survive within the cytoplasm as well take over the molecular machinery of the host within the nuclei 45 . 
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